03 November 2015

Winners announced for the 2015 Movember Clinician Scientist Award

Prostate Cancer Foundation of Australia (PCFA) today announced the winners of the 2015 Movember Clinician Scientist Award. This award is a newly established fellowship that provides qualified clinicians the chance to establish their research career in prostate cancer.

This is the first time that PCFA and the Movember Foundation have accepted applications for the "Clinician Scientist Award", with the Movember Foundation investing over $1 million for the new award category. Two top Australian clinicians have been awarded fellowships to help them work closely with laboratory scientists and further their careers in prostate cancer research.

The recipients for the 2015 Movember Clinician Scientist Awards are:

  • Dr Ian Vela from the Queensland University of Technology, awarded for his work into precision medicine in advanced and oligometastatic prostate cancer.
  • Dr Kate Mahon from the Garvan Institute of Medical Research, awarded for her work in Docetaxel (chemotherapy) resistance in advanced metastatic prostate cancer.

Each award recipient will receive up to $450,000 to support research into prostate cancer biology, treatment, diagnosis, survivorship and prevention.

According to Paul Villanti, Executive Director at the Movember Foundation, it is exciting to offer clinicians a chance to secure a new fellowship in prostate cancer research.

"The Clinician Scientist Award aims to bridge the gap between clinical and laboratory work. We are proud to have given two outstanding clinicians the chance to advance their careers and continue their valuable research into prostate cancer," said Mr Villanti.

Associate Professor Anthony Lowe, Chief Executive Officer of PCFA, says the clinicians who have been awarded the fellowships have demonstrated promising work into treatment of prostate cancer at different stages.

"PCFA and the Movember Foundation are committed to supporting Australia’s clinicians and scientists, and creating new ways to encourage development in prostate cancer research. We are looking forward to offering more clinicians funding opportunities in the near future and giving them a chance to work more closely with laboratory scientists to improve clinical practice in the prostate cancer field," said Associate Professor Anthony Lowe.

PCFA will announce winners in the Clinical Trials, Young Investigator and New Concept Grants category in late November.

PCFA and the Movember Foundation continue to work collaboratively to offer research grants to Australian scientists. More than $50 million has been invested nationally into prostate cancer research since 2004.